Liraglutide improves follicle development in polycystic ovary syndrome by inhibiting CXCL10 secretion
Abstract Background At present, a number of clinical trials have been carried out on GLP-1 receptor agonist liraglutide in the treatment of polycystic ovary syndrome (PCOS). However, the effect of liraglutide on follicle development and its specific mechanism are still unclear. Methods RNA sequencin...
Guardado en:
| Autores principales: | , , , , |
|---|---|
| Formato: | Libro |
| Publicado: |
BMC,
2024-08-01T00:00:00Z.
|
| Materias: | |
| Acceso en línea: | Connect to this object online. |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Internet
Connect to this object online.3rd Floor Main Library
| Número de Clasificación: |
A1234.567 |
|---|---|
| Copia 1 | Disponible |